FDA
-
-
-
-
-
-
-
Xencor and UCLA Enter Collaboration to Discover and Develop Novel XmAb® Therapeutics
-
-
-
-
-
-
-
Xencor Earns Milestone Payment from MorphoSys for FDA Approval of Monjuvi® (tafasitamab-cxix) in the United States
-
-
-
-
-
-
-
Xencor (XNCR) Reports Partial Clinical Hold Lifted on Phase 1 Study of XmAb14045
-
-
-
-
-
-
-
Xencor Reports Third Quarter 2018 Financial Results
-
-
-
-
-
-
-
Xencor Reports Second Quarter 2017 Financial Results
-
-
-
-
-
251,776 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All